The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Steffan T. Nawrocki; Yingchun Han; Valeria Visconte; Bartlomiej Przychodzen; Claudia M. Espitia; James Phillips; Faiz - Anwer; Anjali Advani; Hetty E. Carraway; Kevin R. Kelly; Mikkael A. Sekeres; Jaroslaw P. Maciejewski; Jennifer S. Carew

doi:10.1038/s41375-019-0529-2

The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Steffan T. Nawrocki
, Yingchun Han
, Valeria Visconte
, Bartlomiej Przychodzen
, Claudia M. Espitia
, James Phillips
, Faiz - Anwer
, Anjali Advani
, Hetty E. Carraway
, Kevin R. Kelly
, Mikkael A. Sekeres
, Jaroslaw P. Maciejewski
, Jennifer S. Carew

Medicine

Research output: Contribution to journal › Letter › peer-review

38 Scopus citations

Original language	English (US)
Pages (from-to)	2971-2974
Number of pages	4
Journal	Leukemia
Volume	33
Issue number	12
DOIs	https://doi.org/10.1038/s41375-019-0529-2
State	Published - Dec 1 2019

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-019-0529-2

Cite this

@article{628cacaae6784cbdbb76210c325f805e,

title = "The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine",

author = "Nawrocki, \{Steffan T.\} and Yingchun Han and Valeria Visconte and Bartlomiej Przychodzen and Espitia, \{Claudia M.\} and James Phillips and Anwer, \{Faiz -\} and Anjali Advani and Carraway, \{Hetty E.\} and Kelly, \{Kevin R.\} and Sekeres, \{Mikkael A.\} and Maciejewski, \{Jaroslaw P.\} and Carew, \{Jennifer S.\}",

note = "Funding Information: Acknowledgements This project was supported by grants from the National Cancer Institute (R01CA172443 to JSC and R01CA190789 to STN) and the University of Arizona Cancer Center Support Grant P30CA023074.",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41375-019-0529-2",

language = "English (US)",

volume = "33",

pages = "2971--2974",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "12",

}

TY - JOUR

T1 - The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

AU - Nawrocki, Steffan T.

AU - Han, Yingchun

AU - Visconte, Valeria

AU - Przychodzen, Bartlomiej

AU - Espitia, Claudia M.

AU - Phillips, James

AU - Anwer, Faiz -

AU - Advani, Anjali

AU - Carraway, Hetty E.

AU - Kelly, Kevin R.

AU - Sekeres, Mikkael A.

AU - Maciejewski, Jaroslaw P.

AU - Carew, Jennifer S.

N1 - Funding Information: Acknowledgements This project was supported by grants from the National Cancer Institute (R01CA172443 to JSC and R01CA190789 to STN) and the University of Arizona Cancer Center Support Grant P30CA023074.

PY - 2019/12/1

Y1 - 2019/12/1

UR - https://www.scopus.com/pages/publications/85069939537

UR - https://www.scopus.com/pages/publications/85069939537#tab=citedBy

U2 - 10.1038/s41375-019-0529-2

DO - 10.1038/s41375-019-0529-2

M3 - Letter

C2 - 31358855

AN - SCOPUS:85069939537

SN - 0887-6924

VL - 33

SP - 2971

EP - 2974

JO - Leukemia

JF - Leukemia

IS - 12

ER -

The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this